albendazole has been researched along with Lupus Erythematosus, Systemic in 1 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| " An 8-year-old girl was treated with albendazole therapy for common toxocariasis, but she developed two weeks later, asthenia, fever, infiltrated maculopapular eruption of the face, peripheral vascular disease with necrosis of the fingers and inflammatory anemia with proteinuria." | 3.81 | Toxocara canis infection: Unusual trigger of systemic lupus erythematosus. ( Baudouin, V; Bourrat, E; Deschênes, G; Fila, M; Guillem, C; Levy, M; Peuchmaur, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levy, M | 1 |
| Bourrat, E | 1 |
| Baudouin, V | 1 |
| Guillem, C | 1 |
| Peuchmaur, M | 1 |
| Deschênes, G | 1 |
| Fila, M | 1 |
1 other study available for albendazole and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Toxocara canis infection: Unusual trigger of systemic lupus erythematosus.
Topics: Albendazole; Animals; Antibodies, Antinuclear; Antiprotozoal Agents; Child; Female; Glucocorticoids; | 2015 |